Work

[Efficacy and prognostic factors of allogeneic hematopoietic stem cell transplantation treatment for T lymphoblastic leukemia/lymphoma].

Year: 2023

Type: other

Abstract: Allo-HSCT could be an effective consolidation therapy for adult and adolescent patients with T-ALL/LBL. Different donor sources did not affect survival. Allo-HSCT may overcome the adverse influence of ETP-ALL/LBL on OS.

Source: PubMed

DOI: 10.3760/cma.j.issn.0253-2727.2023.05.006

Authors: L Luo, Y Jiao, P Yang, Y Li, W Y Huang, X Y Ke, D H Zou, H M Jing

Institutions: Peking University Third Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Institute of Hematology & Blood Diseases Hospital, State Key Laboratory of Experimental Hematology

Language: English

Topic: Hematopoietic Stem Cell Transplantation

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W4385680691

Cites: 21

Cited by: 1

Related to: 10